Year To Quarter End Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7710547

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Year to quarter end statement of income
Statement of income
Net sales
46,074,000,000 JPY
45,900,000,000 JPY
Cost of sales
32,644,000,000 JPY
32,630,000,000 JPY
Gross profit (loss)
13,429,000,000 JPY
13,269,000,000 JPY
Selling, general and administrative expenses
12,168,000,000 JPY
12,471,000,000 JPY
Selling, general and administrative expenses
Salaries
2,490,000,000 JPY
2,473,000,000 JPY
Depreciation
503,000,000 JPY
493,000,000 JPY
Operating profit (loss)
1,261,000,000 JPY
798,000,000 JPY
Non-operating income
Interest income
20,000,000 JPY
20,000,000 JPY
Dividend income
71,000,000 JPY
65,000,000 JPY
Non-operating income
409,000,000 JPY
410,000,000 JPY
Non-operating expenses
Interest expenses
226,000,000 JPY
220,000,000 JPY
Non-operating expenses
391,000,000 JPY
376,000,000 JPY
Ordinary profit (loss)
1,279,000,000 JPY
832,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
567,000,000 JPY
Extraordinary income
JPY
567,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
3,000,000 JPY
JPY
Extraordinary losses
23,000,000 JPY
38,000,000 JPY
Profit (loss) before income taxes
1,255,000,000 JPY
1,361,000,000 JPY
Income taxes - current
374,000,000 JPY
386,000,000 JPY
Income taxes - deferred
-12,000,000 JPY
5,000,000 JPY
Income taxes
361,000,000 JPY
391,000,000 JPY
Profit (loss)
894,000,000 JPY
894,000,000 JPY
894,000,000 JPY
894,000,000 JPY
970,000,000 JPY
970,000,000 JPY
970,000,000 JPY
970,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.